Common Contracts
1 similar Licensing Agreement contracts
Licensing agreement for subcutaneous Cinryze (C1 esterase inhibitor)Licensing Agreement • November 29th, 2022 • Delaware
Worldwide exclusive licensing agreement for the use of rHuPH20 (recombinant human hyaluronidase) in the development of a subcutaneous formulation of Cinryze (C1 esterase inhibitor [human]).
